Suchergebnisse - "Agnelli, Luca"

PubPharm (149)

1

PROACT 2.0 : A new open-source tool to improve patient-doctor communication in clinical trials

enthalten in: Tumori | 2024

von Agnelli, L. | Villa, A. | Butt, F. | +16

2

Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma

enthalten in: Blood advances | 2024

von Carniti, C. | Caldarelli, N. | Agnelli, L. | +13

3

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies : Integration of Real-World Data and Translational Research

enthalten in: Clinical lung cancer | 2024

von Prelaj, A. | Ganzinelli, M. | Provenzano, L. | +63

4

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma

enthalten in: Haematologica | 2024

von Garcia, J. | Storti, P. | Iannozzi, N. | +14

5

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade : the PRESSING-HER2 Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Randon, G. | Nakamura, Y. | Yaeger, R. | +19

CommentIn: Clin Cancer Res. 2024 Jan 17;30(2):260-262. - PMID 37975903

6

Public and patient involvement : a survey on knowledge, experience and opinions among researchers within a precision oncology European project

enthalten in: BMC cancer | 2023

von Mosconi, P. | Colombo, C. | Paletta, P. | +105

7

A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei

enthalten in: Biomedicines | 2023

von Kusamura, S. | Busico, A. | Conca, E. | +15

8

Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care

enthalten in: JCO precision oncology | 2023

von Vingiani, A. | Agnelli, L. | Duca, M. | +30

9

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50% : a multiomics analysis

enthalten in: Journal for immunotherapy of cancer | 2023

von Lo Russo, G. | Prelaj, A. | Dolezal, J. | +33

ErratumIn: J Immunother Cancer. 2024 Jan 11;12(1):. - PMID 38212129

10

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma

enthalten in: Scientific reports | 2023

von Azzollini, J. | Agnelli, L. | Conca, E. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]